William Stephens, MD
Hand Surgery · Tallahassee, FLNPI 1366527897
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,500 of the $5,215 with a category attached, or 67.1%. Exsomed Corporation accounts for 67.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,576 and has fallen 96.9% since, to $49 in 2025.
Across 24 payments — averaging $217.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exsomed Corporation$4K
- CGG Medical Inc$917
- Arthrex$496
- Bioventus LLC$164
- Dynasplint Systems Inc.$55
- Axogen$49
- plus $34 from 2 others
Across 1 payment — averaging $11,537 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$12K
What the payments were for
- Consulting fees$3,50067%
- Travel & lodging$3867%
- Food & beverage$4128%
- Education$91718%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exsomed Corporation | 4 | $3,500 |
| CGG Medical Inc | 1 | $917 |
| Arthrex | 10 | $496 |
| Bioventus LLC | 3 | $164 |
| Dynasplint Systems Inc. | 2 | $55 |
| Axogen | 2 | $49 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Stimwave Technologies Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INnate Implant$4,200
- InFrame Implant$2,100
- ArrowPhix System$2,100
- ArcPhix System$2,100
- Durolane$120
How this compares
$5,215 in reported general payments places this provider in the 60th percentile of 173 hand surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 163 | $1,076 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 83 | $998 |
| Methylprednisolone | 24 | $302 |
| Meloxicam | 41 | $239 |
| Diclofenac Sodium | 13 | $206 |
| Celecoxib | 13 | $150 |
| Doxycycline Hyclate | 27 | $146 |
| Gabapentin | 17 | $113 |
| Oxycodone Hcl | 16 | $81 |
| Tramadol Hcl | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Tallahassee
- David AlvarezTallahassee$6K
- Jorge Orbay-CerratoMiami$12.5M
- Peter EvansStuart$525K
- Nirav GuptaOcala$491K
- Francisco RubioMiami$345K
- Justin ZumstegOrlando$133K
- Maria-Carolina Orbay AranMiami$108K
- Paul PatersonVero Beach$104K
- Helen Hui-ChouMiami$95K
- Philipp StreubelWeston$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.